Listed

MoonLake Immunotherapeutics

MLTXNasdaqCIK 1821586HealthcareFiscal year ends Dec 31

Reports and events: 103 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

MoonLake Immunotherapeutics, Reports and events
FiledFormWhat it isAccession number
2024-02-2609:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-24-016737
2023-11-1408:05 ET10-QQuarterly reportPeriod 2023-09-300001821586-23-000022
2023-11-1408:01 ET8-K2.02 Results of operations0001821586-23-000020
2023-11-0607:55 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-23-036888
2023-10-1606:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013762-23-003933
2023-09-1111:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-23-075653
2023-09-0117:00 ET8-K5.02 Departure or appointment of officers or directors0001213900-23-073296
2023-08-1008:17 ET10-QQuarterly reportPeriod 2023-06-300001821586-23-000015
2023-08-1008:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-23-065274
2023-06-3016:41 ETSC 13D/AOwnership report, active investor, amended0001193805-23-000934
2023-06-2916:13 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-23-023905
2023-06-2608:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-023381
2023-06-0716:31 ET8-K5.07 Shareholder vote results0001213900-23-047184
2023-05-1916:30 ET8-K5.02 Departure or appointment of officers or directors0001213900-23-041556
2023-05-1116:03 ET10-QQuarterly reportPeriod 2023-03-310001821586-23-000012
2023-04-2616:31 ETDEF 14AProxy statementPeriod 2023-06-070001140361-23-020595
2023-04-1909:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-23-030849
2023-03-2008:44 ET10-KAnnual reportPeriod 2022-12-310001821586-23-000007
2023-03-2007:44 ET8-K2.02 Results of operations0001821586-23-000004
2023-03-1017:07 ET8-K7.01 Regulation FD disclosure0001213900-23-019254
2022-11-1407:55 ET10-QQuarterly reportPeriod 2022-09-300001821586-22-000009
2022-08-1216:04 ET10-QQuarterly reportPeriod 2022-06-300001821586-22-000006
2022-07-2608:43 ETS-1/ARegistration statement, amended0001213900-22-041495
2022-07-1517:08 ETS-1/ARegistration statement, amended0001213900-22-039695
2022-06-1716:05 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001213900-22-033592
2022-06-0708:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-22-031476
2022-05-1616:10 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001213900-22-027102
2022-05-1616:05 ET10-QQuarterly reportPeriod 2022-03-310001213900-22-027086
2022-05-0216:10 ETS-1/ARegistration statement, amended0001213900-22-023173
2022-04-1816:49 ETSC 13DOwnership report, active investor0000921895-22-001288
2022-04-1116:40 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-22-019217
2022-03-3117:29 ET8-K5.07 Shareholder vote results0001213900-22-016984
2022-03-2416:49 ET8-K2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001213900-22-014894
2022-03-1416:16 ETS-1/ARegistration statement, amended0001213900-22-012161
2022-03-0816:17 ETS-1/ARegistration statement, amended0001213900-22-011107
2022-02-2516:27 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-22-009481
2022-02-1716:07 ET10-KAnnual reportPeriod 2021-12-310001213900-22-008253
2022-02-1121:52 ETS-1Registration statement0001213900-22-006626
2021-12-1417:19 ET10-Q/AQuarterly report, amendedPeriod 2021-09-300001213900-21-065247
2021-12-1417:18 ET10-K/AAnnual report, amendedPeriod 2020-12-310001213900-21-065246
2021-12-0316:04 ET8-K4.02 Non-reliance on financial statements0001213900-21-063323
2021-11-1216:06 ET10-QQuarterly reportPeriod 2021-09-300001213900-21-058671
2021-10-0407:07 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-21-051257
2021-08-1616:03 ET10-QQuarterly reportPeriod 2021-06-300001213900-21-042958
2021-05-2116:14 ET10-QQuarterly reportPeriod 2021-03-310001213900-21-028399
2021-05-0316:00 ET8-K5.02 Departure or appointment of officers or directors0001213900-21-024220
2021-03-3109:59 ET10-KAnnual reportPeriod 2020-12-310001213900-21-019007
2020-12-0316:31 ET10-QQuarterly reportPeriod 2020-09-300001213900-20-040763
2020-10-2817:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-033731
2020-10-2217:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-032858

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.